AI assistant
HERBALIFE LTD. — Director's Dealing 2012
May 3, 2012
32337_dirs_2012-05-03_9ce999d6-2858-4866-a4be-cf5ef4271d5f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2012-05-01
Reporting Person: JOHNSON MICHAEL (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-01 | Common Stock | M | 175580 | $12.32 | Acquired | 1082453 | Direct |
| 2012-05-01 | Common Stock | S | 4775 | $70.58 | Disposed | 1077678 | Direct |
| 2012-05-01 | Common Stock | S | 23625 | $69.87 | Disposed | 1054053 | Direct |
| 2012-05-01 | Common Stock | S | 29930 | $68.70 | Disposed | 1024123 | Direct |
| 2012-05-01 | Common Stock | S | 58050 | $68.05 | Disposed | 966073 | Direct |
| 2012-05-01 | Common Stock | S | 44032 | $66.91 | Disposed | 922041 | Direct |
| 2012-05-01 | Common Stock | S | 15168 | $66.08 | Disposed | 906873 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-01 | Non-Qualified Stock Option | $12.32 | M | 175580 | Disposed | 2013-04-03 | Common Stock (175580) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 79420 | Indirect |
| Common Stock | 79420 | Indirect |
| Common Stock | 113122 | Indirect |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2011.
F2: This transaction was executed in multiple trades at prices ranging from $70.45 to $70.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $69.44 to $70.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $68.43 to $69.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5: This transaction was executed in multiple trades at prices ranging from $67.42 to $68.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6: This transaction was executed in multiple trades at prices ranging from $66.41 to $67.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7: This transaction was executed in multiple trades at prices ranging from $65.40 to $66.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8: These options were fully vested as of June 30, 2008.
F9: These options were granted on April 3, 2003 and were scheduled to expire and would no longer be exercisable as of April 3, 2013.